
### [NCIT:C4684](http://purl.obolibrary.org/obo/NCIT_C4684)
**Label:** Nasal Type Extranodal NK/T-Cell Lymphoma

**Subclasses:** [NCIT:C8669](http://purl.obolibrary.org/obo/NCIT_C8669) (Refractory Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C5026](http://purl.obolibrary.org/obo/NCIT_C5026) (Recurrent Nasal Type NK/T-Cell Lymphoma), [NCIT:C8674](http://purl.obolibrary.org/obo/NCIT_C8674) (Stage III Nasal Type NK/T-Cell Lymphoma), [NCIT:C68692](http://purl.obolibrary.org/obo/NCIT_C68692) (Childhood Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C115154](http://purl.obolibrary.org/obo/NCIT_C115154) (Adult Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C45268](http://purl.obolibrary.org/obo/NCIT_C45268) (Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma), [NCIT:C8675](http://purl.obolibrary.org/obo/NCIT_C8675) (Stage IV Nasal Type NK/T-Cell Lymphoma), [NCIT:C8673](http://purl.obolibrary.org/obo/NCIT_C8673) (Stage II Nasal Type NK/T-Cell Lymphoma), [NCIT:C8670](http://purl.obolibrary.org/obo/NCIT_C8670) (Stage I Nasal Type NK/T-Cell Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 52.91%
- [NCIT:C39600](http://purl.obolibrary.org/obo/NCIT_C39600) (Neoplastic Medium-Sized T-Lymphocyte) 52.50%
- [NCIT:C37017](http://purl.obolibrary.org/obo/NCIT_C37017) (Anaplastic Large T-Lymphocyte) 52.50%
- [NCIT:C37012](http://purl.obolibrary.org/obo/NCIT_C37012) (Neoplastic T-Immunoblast) 52.50%
- [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) and [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) 52.50%
- [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) and [NCIT:C37018](http://purl.obolibrary.org/obo/NCIT_C37018) (Anaplastic Large Lymphocyte) 52.50%
- [NCIT:C37009](http://purl.obolibrary.org/obo/NCIT_C37009) (Neoplastic Immunoblast) and [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) 52.50%
- [NCIT:C36734](http://purl.obolibrary.org/obo/NCIT_C36734) (Anaplastic Cell) and [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) 52.50%
- [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) and [NCIT:C37018](http://purl.obolibrary.org/obo/NCIT_C37018) (Anaplastic Large Lymphocyte) and [NCIT:C39678](http://purl.obolibrary.org/obo/NCIT_C39678) (Anaplastic T-Lymphocyte) 52.50%
- [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) 50.80%
- [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) and (not ([NCIT:C133895](http://purl.obolibrary.org/obo/NCIT_C133895) (Stage I Small Intestinal Adenocarcinoma AJCC v8))) 50.80%
- [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) and (not ([NCIT:C133894](http://purl.obolibrary.org/obo/NCIT_C133894) (Stage 0 Small Intestinal Adenocarcinoma AJCC v8))) 50.80%
- [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) and (not ([NCIT:C13384](http://purl.obolibrary.org/obo/NCIT_C13384) (7q))) 50.80%
- [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) and (not ([NCIT:C133804](http://purl.obolibrary.org/obo/NCIT_C133804) (Stage IV Anal Cancer AJCC v8))) 50.80%
- [NCIT:C37016](http://purl.obolibrary.org/obo/NCIT_C37016) (Neoplastic Large T-Lymphocyte) and (not ([NCIT:C133800](http://purl.obolibrary.org/obo/NCIT_C133800) (Stage III Anal Cancer AJCC v8))) 50.80%


